A study by the National Institute of Health of America showed that Remdesivir, an anti-viral drug, produced promising results in treating the Corona virus as part of preliminary laboratory experiments on monkeys.
The study included intentionally injecting two groups of six rhesus macaques with the Corona virus, and studying the effect of the drug on one of them.
After 12 hours of monkeys infected with the virus, scientists gave the drug “Remdisevir” to the first group of monkeys, once a day over a period of 6 days, the same schedule of doses that are given to humans infected with the virus.
Scientists found a noticeable improvement in symptoms in monkeys after the first dose of the drug, and at the end of the experiment, scientists found that all monkeys in the first group improved except for one monkey and found slight difficulty breathing, while all the monkeys of the second group that were not given the drug suffered from difficulty breathing .
Scientists have also found that the amount of virus present in the lungs of the first group monkeys is much lower than that found in the lungs of the first group monkeys, and that the virus has caused less damage to the lungs of the first group monkeys.
The National Institute of Health said: “Early treatment with the anti-viral drug Remedies significantly reduces clinical disease and damage to the lungs in macaques infected with Corona virus.”
One of dozens of drugs being tested to test its efficacy in treating the Coronavirus, is the drug Remedisfer, produced by the American company, Gilead Sciences.
The drug’s effectiveness in treating the virus in humans was first tested in a clinical trial at the University of Nebraska Medical Center in Omaha, USA, in February, and the University of Chicago Medical Center.
Results of experiments reported a rapid improvement in fever and respiratory symptoms in 113 HIV-positive patients, all of whom were discharged from hospital.
Ben Carson, the US Secretary of Housing and Urban Development, is a prominent surgeon and member of the White House Coronavirus Task Force, who in turn has said it is a promising drug for treating the Corona virus and has been used in several places.
It is noteworthy that the drug is the fruit of cooperation, to find antiviral drugs during the Ebola epidemic, in West Africa, between 2013 and 2016, and the efforts of Gilliad, the US Army Medical Research Institute for Infectious Diseases, and the US Centers for Disease Control and Prevention joined forces. It works by disrupting the molecular mechanisms, which some viruses use to build their genes as they reproduce.